Compare Elder Pharma with Dr. Reddys - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ELDER PHARMA vs DR. REDDYS LAB - Comparison Results

DR. REDDYS LAB 
   Change

Dr. Reddy's is a leading pharmaceutical company in the country with presence across the value chain. While the global generics business accounted for 69% of total revenues in FY12, the PSAI business (Pharma Services and Active Ingredients - PSAI) con... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ELDER PHARMA DR. REDDYS LAB ELDER PHARMA/
DR. REDDYS LAB
 
P/E (TTM) x -0.2 21.4 - View Chart
P/BV x 0.1 3.2 3.2% View Chart
Dividend Yield % 0.0 0.7 -  

Financials

 ELDER PHARMA   DR. REDDYS LAB
EQUITY SHARE DATA
    ELDER PHARMA
Jun-14
DR. REDDYS LAB
Mar-19
ELDER PHARMA/
DR. REDDYS LAB
5-Yr Chart
Click to enlarge
High Rs3802,875 13.2%   
Low Rs1881,888 10.0%   
Sales per share (Unadj.) Rs491.2930.2 52.8%  
Earnings per share (Unadj.) Rs-3.2117.4 -2.7%  
Cash flow per share (Unadj.) Rs14.4185.8 7.8%  
Dividends per share (Unadj.) Rs020.00 0.0%  
Dividend yield (eoy) %00.8 0.0%  
Book value per share (Unadj.) Rs376.5844.4 44.6%  
Shares outstanding (eoy) m20.54166.07 12.4%   
Bonus/Rights/Conversions -ESOP-  
Price / Sales ratio x0.62.6 22.6%   
Avg P/E ratio x-89.320.3 -440.1%  
P/CF ratio (eoy) x19.712.8 153.7%  
Price / Book Value ratio x0.82.8 26.7%  
Dividend payout %017.0 0.0%   
Avg Mkt Cap Rs m5,833395,496 1.5%   
No. of employees `000NA22.0 0.0%   
Total wages/salary Rs m2,17933,562 6.5%   
Avg. sales/employee Rs ThNM7,032.8-  
Avg. wages/employee Rs ThNM1,527.9-  
Avg. net profit/employee Rs ThNM887.7-  
INCOME DATA
Net Sales Rs m10,089154,482 6.5%  
Other income Rs m2573,375 7.6%   
Total revenues Rs m10,346157,857 6.6%   
Gross profit Rs m-79231,782 -2.5%  
Depreciation Rs m36111,348 3.2%   
Interest Rs m2,756889 310.0%   
Profit before tax Rs m-3,65322,920 -15.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m0438 0.0%   
Extraordinary Inc (Exp) Rs m3,7130-   
Tax Rs m1253,858 3.2%   
Profit after tax Rs m-6519,500 -0.3%  
Gross profit margin %-7.820.6 -38.2%  
Effective tax rate %-3.416.8 -20.4%   
Net profit margin %-0.612.6 -5.1%  
BALANCE SHEET DATA
Current assets Rs m9,240111,101 8.3%   
Current liabilities Rs m9,99858,973 17.0%   
Net working cap to sales %-7.533.7 -22.3%  
Current ratio x0.91.9 49.1%  
Inventory Days Days4679 58.4%  
Debtors Days Days6094 63.6%  
Net fixed assets Rs m10,124101,245 10.0%   
Share capital Rs m206830 24.8%   
"Free" reserves Rs m5,582139,406 4.0%   
Net worth Rs m7,734140,236 5.5%   
Long term debt Rs m4,88922,000 22.2%   
Total assets Rs m22,882224,656 10.2%  
Interest coverage x-0.326.8 -1.2%   
Debt to equity ratio x0.60.2 403.0%  
Sales to assets ratio x0.40.7 64.1%   
Return on assets %11.89.1 129.6%  
Return on equity %-0.813.9 -6.1%  
Return on capital %22.314.9 149.3%  
Exports to sales %3.00-   
Imports to sales %0.40-   
Exports (fob) Rs m307NA-   
Imports (cif) Rs m43NA-   
Fx inflow Rs m30788,673 0.3%   
Fx outflow Rs m12519,104 0.7%   
Net fx Rs m18169,569 0.3%   
CASH FLOW
From Operations Rs m11,75428,704 40.9%  
From Investments Rs m-561-7,727 7.3%  
From Financial Activity Rs m-6,762-21,326 31.7%  
Net Cashflow Rs m4,432-314 -1,411.4%  

Share Holding

Indian Promoters % 39.6 25.5 155.3%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 7.5 5.4 138.9%  
FIIs % 16.8 35.3 47.6%  
ADR/GDR % 0.0 18.5 -  
Free float % 36.1 15.3 235.9%  
Shareholders   16,479 75,885 21.7%  
Pledged promoter(s) holding % 77.6 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ELDER PHARMA With:   JUBILANT LIFE SCIENCES  DR. DATSONS LABS  WOCKHARDT  GSK PHARMA  PANACEA BIOTECH  

Compare ELDER PHARMA With:   MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Opens Marginally Higher; Energy & Realty Stocks Lead(09:30 am)

Asian share markets are higher today as Britain and the EU made headway on a Brexit deal ahead of a leaders' summit.

Related Views on News

DR. REDDYS LAB Announces Quarterly Results (3QFY19); Net Profit Up 67.0% (Quarterly Result Update)

Feb 4, 2019 | Updated on Feb 4, 2019

For the quarter ended December 2018, DR. REDDYS LAB has posted a net profit of Rs 5 bn (up 67.0% YoY). Sales on the other hand came in at Rs 39 bn (up 0.8% YoY). Read on for a complete analysis of DR. REDDYS LAB's quarterly results.

DR. REDDYS LAB Announces Quarterly Results (1QFY19); Net Profit Up 614.9% (Quarterly Result Update)

Jul 27, 2018 | Updated on Jul 27, 2018

For the quarter ended June 2018, DR. REDDYS LAB has posted a net profit of Rs 5 bn (up 614.9% YoY). Sales on the other hand came in at Rs 37 bn (up 12.1% YoY). Read on for a complete analysis of DR. REDDYS LAB's quarterly results.

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

More Views on News

Most Popular

My 3 Best Small-cap Stocks to Get Rich in this Market Rebound(Profit Hunter)

Oct 14, 2019

This is once in a decade opportunity to make a killing from smallcap rebound.

Finally, Is the Share Price of Yes Bank Ready for a Rebound?(The 5 Minute Wrapup)

Oct 7, 2019

Here's what every individual investor must know about Yes Bank...

Rebound Riches Could be Yours With These Stocks(Profit Hunter)

Oct 4, 2019

The secret to multibagger is not big businesses, but great managements... Here's how to find them to make the most of once in a decade rebound opportunity.

The One Stock I Like in this Market(The 5 Minute Wrapup)

Oct 10, 2019

There are rare periods in markets when you get good quality stocks at attractive valuations. Is this one such period?

5 Smart Money Stocks to Profit from the Market Rebound(The 5 Minute Wrapup)

Oct 11, 2019

Now is the time to put money in these 5 stocks to take advantage of the recovery in the economy and the markets.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

ELDER PHARMA SHARE PRICE


Sep 12, 2016 (Close)

TRACK ELDER PHARMA

  • Track your investment in ELDER PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ELDER PHARMA - IPCA LABS COMPARISON

COMPARE ELDER PHARMA WITH

MARKET STATS